A shifting paradigm in the aetiology of oral and pharyngeal cancer in Sri Lanka: a case-control study providing serologic evidence for the role of oncogenic HPV types 16 and 18.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4407420)

Published in Infect Agent Cancer on April 16, 2015

Authors

Suvanthee Kushani Gunasekera1, Kanthi Angela Perera2, Chandrika Fernando3, Preethi Vidya Udagama1

Author Affiliations

1: Department of Zoology, Faculty of Science, University of Colombo, Colombo 03, Sri Lanka.
2: National Cancer Institute, Maharagama, Sri Lanka.
3: Sri Lanka Institute for Information Technology, Colombo, Sri Lanka.

Articles cited by this

Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39

The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73

Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev (2005) 9.47

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst (2003) 6.28

Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst (2000) 5.32

Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol (2013) 3.76

Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2009) 3.33

Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum (2004) 3.29

Oral cancer prevention and control--the approach of the World Health Organization. Oral Oncol (2008) 2.92

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology (1996) 2.83

The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev (2003) 2.52

Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer (2007) 1.78

Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg (2001) 1.71

Current topics in the epidemiology of oral cavity and oropharyngeal cancers. Head Neck (2007) 1.67

Causes of oral cancer--an appraisal of controversies. Br Dent J (2009) 1.65

The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med (2011) 1.40

Human papillomavirus seropositivity and risks of head and neck cancer. Int J Cancer (2007) 1.39

Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncol (2007) 1.34

Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One (2012) 1.14

Oropharyngeal carcinoma in non-smokers and non-drinkers: a role for HPV. Oral Oncol (2008) 1.13

Prognostic implications of HPV in oropharyngeal cancer. N Engl J Med (2010) 1.11

Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma. Head Face Med (2010) 1.09

Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health (2008) 1.09

The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview. Infect Agent Cancer (2011) 1.04

The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population. Infect Agent Cancer (2007) 1.03

Optimization of a human papillomavirus-specific enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (2002) 1.02

Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study. Infect Agent Cancer (2011) 1.01

Prevalence of oral cancer and pre-cancer and associated risk factors among tea estate workers in the central Sri Lanka. J Oral Pathol Med (2007) 0.97

Human papillomavirus as an independent predictor in oral squamous cell cancer. Int J Oral Sci (2009) 0.93

Risk factors for oral squamous cell carcinoma in young and older Brazilian patients: a comparative analysis. Med Oral Patol Oral Cir Bucal (2008) 0.92

Oral cancer, HPV infection and evidence of sexual transmission. Med Oral Patol Oral Cir Bucal (2013) 0.90

Demographic, aetiological and survival differences of oral squamous cell carcinoma in the young and the old in Sri Lanka. Oral Oncol (2006) 0.90

Smokeless tobacco use in Sri Lanka. Indian J Cancer (2013) 0.90

New Approaches to Immunotherapy for HPV Associated Cancers. Cancers (Basel) (2011) 0.89

Markers of HPV infection and survival in patients with head and neck tumors. Int J Cancer (2013) 0.86

High-risk human papillomaviruses may have an important role in non-oral habits-associated oral squamous cell carcinomas in Taiwan. Am J Clin Pathol (2003) 0.84

Betel-quid chewing with or without tobacco is a major risk factor for oral potentially malignant disorders in Sri Lanka: a case-control study. Oral Oncol (2010) 0.83

Human papillomavirus in oral squamous cells carcinoma in a population of 75 Brazilian patients. Am J Otolaryngol (2007) 0.81

Human papillomavirus prevalence and type-distribution in women with cervical lesions: a cross-sectional study in Sri Lanka. BMC Cancer (2014) 0.78

Persistence or clearance of human papillomavirus infections in women in Ouro Preto, Brazil. Biomed Res Int (2013) 0.77